Literature DB >> 9346947

Alterations in human glomerular epithelial cells interacting with nonenzymatically glycosylated matrix.

U Krishnamurti1, E Rondeau, J D Sraer, A F Michael, E C Tsilibary.   

Abstract

The glomerular epithelial cells and the glomerular basement membrane are important constituents of the permselective barrier in the kidney. These are affected in diabetic nephropathy, one of the long-term complications in diabetic patients. Nonenzymatic glycosylation resulting in the accumulation of advanced glycosylation end products correlates with the development of long-term complications in diabetes. The interaction of cells with extracellular matrix proteins plays a critical role in a variety of biological processes. Recent studies show that cell-matrix interactions mediated by integrins can transduce biochemical signals to the cell interior and regulate cell behavior. In this paper we demonstrate that interactions of human glomerular epithelial cells with a nonenzymatically glycated matrix are altered with defective cell spreading, reduced phosphorylation of focal adhesion kinase and reduced activity of mitogen-activated protein kinase. These data suggest that matrix glycation interferes with normal cell-matrix interactions and intracellular signaling that can potentially result in differential gene expression contributing to the changes seen in diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9346947     DOI: 10.1074/jbc.272.44.27966

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  CCN-2 is up-regulated by and mediates effects of matrix bound advanced glycated end-products in human renal mesangial cells.

Authors:  Xiaoyu Wang; Susan V McLennan; Stephen M Twigg
Journal:  J Cell Commun Signal       Date:  2011-06-02       Impact factor: 5.782

Review 2.  Diabetic kidney disease: a role for advanced glycation end-product receptor 1 (AGE-R1)?

Authors:  Aowen Zhuang; Josephine M Forbes
Journal:  Glycoconj J       Date:  2016-06-06       Impact factor: 2.916

Review 3.  The role of glycation in the pathogenesis of diabetic polyneuropathy.

Authors:  R H King
Journal:  Mol Pathol       Date:  2001-12

Review 4.  Glycosaminoglycan remodeling during diabetes and the role of dietary factors in their modulation.

Authors:  Vemana Gowd; Abhignan Gurukar; Nandini D Chilkunda
Journal:  World J Diabetes       Date:  2016-02-25

5.  Retinal pigment epithelium resurfacing of aged submacular human Bruch's membrane.

Authors:  Vamsi K Gullapalli; Ilene K Sugino; Yancy Van Patten; Sumit Shah; Marco A Zarbin
Journal:  Trans Am Ophthalmol Soc       Date:  2004

Review 6.  Advanced glycation end products and diabetic complications.

Authors:  Varun Parkash Singh; Anjana Bali; Nirmal Singh; Amteshwar Singh Jaggi
Journal:  Korean J Physiol Pharmacol       Date:  2014-02-13       Impact factor: 2.016

7.  AGE-LDL activates Toll like receptor 4 pathway and promotes inflammatory cytokines production in renal tubular epithelial cells.

Authors:  Ao Cheng; Yuanyuan Dong; Fengxin Zhu; Youhua Liu; Fan Fan Hou; Jing Nie
Journal:  Int J Biol Sci       Date:  2013-01-03       Impact factor: 6.580

8.  Effect of irreversibly glycated LDL in human vascular smooth muscle cells: lipid loading, oxidative and inflammatory stress.

Authors:  Anca V Sima; Gabriela M Botez; Camelia S Stancu; Adrian Manea; Monica Raicu; Maya Simionescu
Journal:  J Cell Mol Med       Date:  2010-12       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.